Yahoo · Sep 10, 2026
Cardinal (CAH) Up 2.5% Since Last Earnings Report: Can It Continue?
Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NASDAQ · CAH
Healthcare · Medical - Distribution
$232.65
Down-$2.24 (-0.95%)
Updated Sep 16, 2026, 12:50 PM
SID Score
6.6/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CAH closed at $232.65 after 20 trading sessions, down 0.99% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $233.89 | $234.83 | $230.34 | $232.65 | 1.8M |
| Sep 14, 2026 | $236.76 | $237.565 | $232.60 | $234.89 | 2.17M |
| Sep 11, 2026 | $238.77 | $239.43 | $232.60 | $234.57 | 1.11M |
| Sep 10, 2026 | $241.27 | $242.12 | $235.67 | $236.02 | 1.22M |
| Sep 9, 2026 | $239.02 | $241.64 | $238.405 | $240.00 | 1.03M |
| Sep 8, 2026 | $243.90 | $245.83 | $239.425 | $240.49 | 1.6M |
| Sep 4, 2026 | $246.34 | $249.29 | $246.29 | $247.18 | 1.55M |
| Sep 3, 2026 | $246.11 | $249.26 | $245.82 | $248.61 | 1.39M |
| Sep 2, 2026 | $240.99 | $246.02 | $239.35 | $245.49 | 1.36M |
| Sep 1, 2026 | $236.85 | $240.75 | $236.025 | $239.35 | 1.34M |
| Aug 31, 2026 | $234.92 | $236.97 | $233.51 | $234.62 | 1.67M |
| Aug 28, 2026 | $236.02 | $236.80 | $233.72 | $234.55 | 1.78M |
| Aug 27, 2026 | $236.49 | $237.30 | $234.15 | $235.13 | 1.03M |
| Aug 26, 2026 | $237.90 | $240.88 | $236.445 | $238.40 | 1.47M |
| Aug 25, 2026 | $232.51 | $238.10 | $232.375 | $237.92 | 1.34M |
| Aug 24, 2026 | $229.16 | $232.37 | $227.68 | $232.37 | 1.4M |
| Aug 21, 2026 | $228.80 | $231.29 | $228.16 | $229.51 | 1.39M |
| Aug 20, 2026 | $232.25 | $235.00 | $228.38 | $228.46 | 1.59M |
| Aug 19, 2026 | $236.41 | $238.15 | $232.34 | $234.85 | 1.38M |
| Aug 18, 2026 | $235.17 | $238.24 | $233.94 | $234.98 | 1.79M |
The latest Smart Investors Daily articles mentioning CAH.
CAH research
Company profile and research snapshot.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | RBC Capital | Outperform | — |
| Aug 13, 2026 | JP Morgan | Neutral | — |
| Aug 13, 2026 | TD Cowen | Buy | — |
| Aug 13, 2026 | Barclays | Overweight | — |
| Aug 12, 2026 | Morgan Stanley | Overweight | — |
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo · Sep 9, 2026
On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & Johnson (NYSE:JNJ) or Cardinal Health (NYSE:CAH). Mad Money host Jim Cramer said: Well, I’ll tell you… I think it’s always good to look at Lilly as a stock […]
SeekingAlpha · Sep 9, 2026
Cardinal Health, Inc. (CAH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDTCompany ParticipantsDavid Frost - Vice President of...
Yahoo · Sep 8, 2026
In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CAH.